Sign in

CIK 0001711279

  • Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
821080209
Phone
+1 412-586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
  1. 4 Planned sale Chief Accounting Officer sold 53,428 shares at an average $101.60 ($5,428,115)
  2. 4 Planned sale Director sold 50,000 shares at $95.02 ($4,751,185)
  3. 4 Planned sale Director sold 17,100 shares at $90.74 ($1,551,579)
  4. 4 Planned sale Director sold 7,900 shares at $90.32 ($713,493)
  5. 4 Planned sale President, R&D sold 50,000 shares at an average $87.65 ($4,382,424)
  6. 4 Planned sale President and CEO sold 50,000 shares at an average $87.65 ($4,382,424)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale Director sold 40,000 shares at $83.25 ($3,329,972)
  10. 4 Derivatives Options or other derivatives
  11. 4 Shares withheld for taxes Chief Accounting Officer gave up 2,144 shares (to pay taxes)
  12. 4 Shares withheld for taxes President, R&D gave up 3,057 shares (to pay taxes)
  13. 4 Shares withheld for taxes President and CEO gave up 4,350 shares (to pay taxes)
  14. 4 Open-market sale President, R&D sold 50,000 shares at an average $80.79 ($4,039,744)
  15. 4 Open-market sale President and CEO sold 50,000 shares at an average $80.79 ($4,039,744)
  16. 4 Open-market sale President, R&D sold 7,686 shares at an average $80.08 ($615,525)
  17. 4 Open-market sale President and CEO sold 7,686 shares at an average $80.08 ($615,525)
  18. 4 Open-market sale President, R&D sold 19,422 shares at an average $80.34 ($1,560,411)
  19. 4 Open-market sale President and CEO sold 19,422 shares at an average $80.34 ($1,560,411)
  20. 4 Open-market sale President, R&D sold 21,099 shares at an average $80.10 ($1,689,986)

Page 5 of 10 · 186 filings